Lack of evidence for BCG vaccine protection from severe COVID-19
- PMID: 32994350
- PMCID: PMC7568270
- DOI: 10.1073/pnas.2016733117
Lack of evidence for BCG vaccine protection from severe COVID-19
Conflict of interest statement
The authors declare no competing interest.
Figures
Comment in
-
Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guérin (BCG) vaccination on COVID-19 prevalence and mortality.Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25207-25208. doi: 10.1073/pnas.2017197117. Epub 2020 Sep 29. Proc Natl Acad Sci U S A. 2020. PMID: 32994348 Free PMC article. No abstract available.
Comment on
-
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9. Proc Natl Acad Sci U S A. 2020. PMID: 32647056 Free PMC article.
References
-
- Johns Hopkins University , Coronavirus Resource Center. https://coronavirus.jhu.edu/. Accessed 1 August 2020.
-
- Aaby P. et al., Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J. Infect. Dis. 204, 245–252 (2011). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
